Premenstrual Dysphoric Disorder Prevalence and Symptoms Across Age Groups: A Cross‐Sectional Study
BJOG: An International Journal of Obstetrics & Gynaecology · 2025
DOI: 10.1111/1471-0528.18261 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2025. Verfasst von Adriana Orcesi Pedro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Universidade Estadual de Campinas, Campinas, Brazil. Hauptthemen laut MEDLINE: Premenstrual Dysphoric Disorder. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LIBBS Farmacêutica.
Abstract (Originalsprache)
Objective
To estimate the prevalence and symptom severity of premenstrual dysphoric disorder (PMDD) in Brazilian women according to age groups, and to conduct an association analysis between psychoemotional and somatic symptoms.
Design
Cross‐sectional study.
Setting
303 private clinics across Brazil. Population 45 160 women aged 20–49 years.
Methods
Self‐report questionnaire regarding the prevalence and intensity of premenstrual symptoms. Statistical analysis performed using Pearson's chi‐square test and Poisson regression and multiple logistic regression. Main Outcome Measures Prevalence and intensity of somatic and psychoemotional premenstrual symptoms.
Results
Prevalence of PMDD was 3.57% (95% CI: 3.40–3.75). Psychoemotional symptoms were more prevalent than somatic symptoms, with anxiety/tension (99.9%) and irritability/anger (99.8%) being the most frequently reported symptoms. Weight gain (92.5%) and edema (92.1%) were the most prevalent somatic symptoms. Anxiety/tension and headache occurred independently of other symptoms. Binge eating was associated with weight gain (OR = 2.77, 95% CI [2.11, 3.62]), acne (OR = 2.37, 95% CI [1.79, 3.10]), immunoallergic exacerbations (OR = 1.81, 95% CI [1.26, 2;60]) and edema (OR—0.74, 95% CI [0.55, 0.97]). Affective lability was associated with immunoallergic exacerbations (OR = 1.49, 95% CI [1.16, 1.91]) and mastalgia (OR = 1.29, 95% CI [1.02, 1.63]). Depression was associated with acne (OR = 0.72, 95% CI [0.57, 0.89]) and weight gain (OR = 0.77, 95% CI [0.61, 0.96]).
Conclusions
The prevalence of PMDD was consistent with other population studies. Psychoemotional symptoms were more prevalent. Association analysis provided new insights into premenstrual symptomatology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Universidade Estadual de Campinas, Campinas, Brazil.
- Libbs Farmacêutica Ltda, Scientific Medical Division, São Paulo, Brazil.
- Medical Affairs Division, PostdocLibbs Farmacêutica Ltda, São Paulo, Brazil.
ORCID-Profile: Adriana Orcesi Pedro, Roberto Carmignani Verdade
Förderung
- LIBBS Farmacêutica
Zitieren
APA
Pedro, A. O., Verdade, R. C., Lapa, M. G., Brandão, J. D. P., & Castilho, V. C. (2025). Premenstrual Dysphoric Disorder Prevalence and Symptoms Across Age Groups: A Cross‐Sectional Study. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.18261
Vancouver
Pedro AO, Verdade RC, Lapa MG, Brandão JDP, Castilho VC. Premenstrual Dysphoric Disorder Prevalence and Symptoms Across Age Groups: A Cross‐Sectional Study. BJOG: An International Journal of Obstetrics & Gynaecology. 2025. doi:10.1111/1471-0528.18261
BibTeX
@article{Pedro2025,
author = {Pedro, Adriana Orcesi and Verdade, Roberto Carmignani and Lapa, Maura Gonzaga and Brandão, Juliana Dinéia Perez and Castilho, Vivienne Carduz},
title = {Premenstrual Dysphoric Disorder Prevalence and Symptoms Across Age Groups: A Cross‐Sectional Study},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2025},
doi = {10.1111/1471-0528.18261}
}
EUVIMED